Clinical Trials Directory

Trials / Completed

CompletedNCT04038541

Prebiotic vs Probiotic in Multiple Sclerosis

Prebiotic and Probiotic Treatment Trial in Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized crossover-designed study to explore the immunologic effects of Prebiotics, as opposed to direct supplementation with beneficial bacteria (Probiotics) in the immune system of patients with MS and Clinically Isolated Syndrome (CIS). Eligible patients will take 6 weeks of two different supplements - Prebiotics and Probiotics. Participants will be randomly assigned to take either of two agents for 6 weeks as their first supplement. Then, participants enter a 6-week washout period. After the washout period, participants will take the second supplement for 6 weeks. After taking the second supplement, participants will have a 6-week washout period.

Detailed description

Soluble fibers (prebiotics) are fermented by beneficial bacteria (probiotics) in the colon to produce short-chain fatty acids (SCFAs) which are the main source of nutrition for the cells in the gut. It has been reported that the fermentable fiber inulin and SCFAs may exert some beneficial effects including anti-inflammatory effect on the immune system. To date, the effect of supplementation with fermentable dietary fiber, such as prebiotics in patients with Multiple Sclerosis (MS) has not been investigated.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPrebiotics (Prebiotin Prebiotic Fiber Stick Pac)Commercially available Prebiotin Prebiotic. 2 packets (Inulin 4000 mg), Twice Daily (Total of 16 g Daily)
DIETARY_SUPPLEMENTProbiotics (Visbiome®)Commercially available Probiotics Visbiome extra strength, which is a combination of live lactic acid bacteria probiotics that have been cultivated, freeze-dried and mixed in very high concentrations. 2 packets (450 billion CFU), Twice Daily (Total of 3,600 billion Daily)

Timeline

Start date
2020-03-11
Primary completion
2023-12-30
Completion
2023-12-30
First posted
2019-07-31
Last updated
2024-05-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04038541. Inclusion in this directory is not an endorsement.